120 related articles for article (PubMed ID: 32447219)
21. URB597, an inhibitor of fatty acid amide hydrolase, reduces hyperalgesia in diabetic rats.
Hasanein P; Parviz M; Keshavarz M; Roohbakhsh A
Can J Physiol Pharmacol; 2009 Jun; 87(6):432-9. PubMed ID: 19526037
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats.
Seillier A; Giuffrida A
Pharmacol Biochem Behav; 2011 Jun; 98(4):583-6. PubMed ID: 21421000
[TBL] [Abstract][Full Text] [Related]
23. Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through amygdala long-term depression in male rodents.
Duan T; Gu N; Wang Y; Wang F; Zhu J; Fang Y; Shen Y; Han J; Zhang X
J Psychiatry Neurosci; 2017 Jun; 42(4):230-241. PubMed ID: 28234213
[TBL] [Abstract][Full Text] [Related]
24. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
Murillo-Rodríguez E; Vázquez E; Millán-Aldaco D; Palomero-Rivero M; Drucker-Colin R
Eur J Pharmacol; 2007 May; 562(1-2):82-91. PubMed ID: 17336288
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways.
Su SH; Wu YF; Lin Q; Hai J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1189-1200. PubMed ID: 28825114
[TBL] [Abstract][Full Text] [Related]
26. Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats.
Pędzińska-Betiuk A; Weresa J; Toczek M; Baranowska-Kuczko M; Kasacka I; Harasim-Symbor E; Malinowska B
Br J Pharmacol; 2017 Jul; 174(13):2114-2129. PubMed ID: 28437860
[TBL] [Abstract][Full Text] [Related]
27. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats.
Hasanein P; Teimuri Far M
Pharmacol Biochem Behav; 2015 Apr; 131():130-5. PubMed ID: 25689415
[TBL] [Abstract][Full Text] [Related]
28. Changes in physicochemical properties of kidney cells membrane as a consequence of hypertension and treatment of hypertensive rats with FAAH inhibitor.
Dobrzyńska I; Szachowicz-Petelska B; Weresa J; Figaszewski ZA; Skrzydlewska E
Chem Biol Interact; 2019 Feb; 299():52-58. PubMed ID: 30502333
[TBL] [Abstract][Full Text] [Related]
29. The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues.
Clapper JR; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
Pharmacol Res; 2006 Nov; 54(5):341-4. PubMed ID: 16935521
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test.
Zaitone SA; El-Wakeil AF; Abou-El-Ela SH
Behav Pharmacol; 2012 Aug; 23(4):417-25. PubMed ID: 22750843
[TBL] [Abstract][Full Text] [Related]
31. Fatty acid amide hydrolase inhibitor (URB597) as a regulator of myocardial lipid metabolism in spontaneously hypertensive rats.
Harasim-Symbor E; Polak A; Pędzińska-Betiuk A; Weresa J; Malinowska B; Lewandowska A; Kasacka I; Chabowski A
Chem Phys Lipids; 2019 Jan; 218():141-148. PubMed ID: 30578756
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice.
Hoyer FF; Khoury M; Slomka H; Kebschull M; Lerner R; Lutz B; Schott H; Lütjohann D; Wojtalla A; Becker A; Zimmer A; Nickenig G
J Mol Cell Cardiol; 2014 Jan; 66():126-32. PubMed ID: 24286707
[TBL] [Abstract][Full Text] [Related]
34. Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress.
Bortolato M; Mangieri RA; Fu J; Kim JH; Arguello O; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
Biol Psychiatry; 2007 Nov; 62(10):1103-10. PubMed ID: 17511970
[TBL] [Abstract][Full Text] [Related]
35. Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.
Celorrio M; Fernández-Suárez D; Rojo-Bustamante E; Echeverry-Alzate V; Ramírez MJ; Hillard CJ; López-Moreno JA; Maldonado R; Oyarzábal J; Franco R; Aymerich MS
Brain Behav Immun; 2016 Oct; 57():94-105. PubMed ID: 27318096
[TBL] [Abstract][Full Text] [Related]
36. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
Cross-Mellor SK; Ossenkopp KP; Piomelli D; Parker LA
Psychopharmacology (Berl); 2007 Feb; 190(2):135-43. PubMed ID: 17111174
[TBL] [Abstract][Full Text] [Related]
37. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain.
Jhaveri MD; Richardson D; Kendall DA; Barrett DA; Chapman V
J Neurosci; 2006 Dec; 26(51):13318-27. PubMed ID: 17182782
[TBL] [Abstract][Full Text] [Related]
38. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
39. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test.
Lisboa SF; Resstel LB; Aguiar DC; Guimarães FS
Eur J Pharmacol; 2008 Sep; 593(1-3):73-8. PubMed ID: 18691568
[TBL] [Abstract][Full Text] [Related]
40. Fatty acid amide hydrolase inhibitor URB597 may protect against kainic acid-induced damage to hippocampal neurons: Dependence on the degree of injury.
Mikheeva IB; Shubina L; Matveeva N; Pavlik LL; Kitchigina VF
Epilepsy Res; 2017 Nov; 137():84-94. PubMed ID: 28963903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]